Peachtree Bioresearch Solutions

What Peachtree Bioresearch Solutions does

Peachtree BioResearch Solutions is a full-service Clinical Research Organization (CRO) founded in 2008 and headquartered in Marietta, Georgia, with staff located in over 20 US states. The company delivers an integrated platform of eight clinical research service modules spanning the trial lifecycle: study feasibility, clinical monitoring and site management, project management, data management, biostatistics, quality assurance, medical writing, and medical monitoring. Its core operational technology consists of standard CRO infrastructure including Clinical Trial Management Systems (CTMS), Clinical Data Management Systems (CDMS), Electronic Data Capture (EDC) applications, and CRF imaging systems.

The company's primary differentiation is deep therapeutic specialization in central nervous system (CNS) disorders, oncology, and rare diseases. According to company materials, 90% of staff hold CNS experience, 80% have oncology study experience, and the operations teams have collectively supported over 700 Phase I-IV studies, 175+ interventional CNS studies, and 40+ epilepsy programs across 20+ CNS/Neurology indications. Staff carry a minimum of 10 years of industry experience, with many senior personnel and the full senior management team holding 25+ years of clinical development experience, and the company states turnover is far below industry average.

Peachtree generates revenue through project-based professional services contracts with emerging to mid-sized biotechnology, pharmaceutical, and medical device sponsors. Pricing is not publicly disclosed; clients submit RFI/RFP inquiries to a dedicated business development team led by VP Business Development Rob Kingston, and engagements span from niche projects to full-service Phase I-III support. The company pursues a sales-led GTM motion combining direct outreach, RFP/RFI process, and conference participation (e.g., Outsourcing in Clinical Trials events in New England and SoCal). In May 2025, Peachtree merged with Netherlands-based CRO Julius Clinical to form a fully integrated global CRO with combined therapeutic expertise in CNS, cardio-metabolic, renal, and rare diseases, and is backed by Ampersand Capital Partners.

Name

Peachtree Bioresearch Solutions

Legal name

Peachtree BioResearch Solutions, Inc.

Website

https://peachtreebrs.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

51–100 employees

Short description

Peachtree BioResearch Solutions is a US-based, CNS-focused full-service CRO delivering feasibility, monitoring, data management, biostatistics, and medical writing services to mid-sized biotech, pharma, and medical device sponsors, now merged with Julius Clinical to form a global CRO.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

akta.pro secondary industries

Clinical CROs (Phase I–IV) (HLAGAAAA), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)

Keywords

• Clinical research services
• Contract research organization
• Clinical trial management
• CNS clinical development
• Biostatistics and data management

Headquarters

HQ city

Marietta

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Research Services: Full-service CRO providing clinical development services for emerging to mid-sized biotechnology, pharmaceutical, and medical device companies. Services range from niche projects to full-service support across Phase I-III clinical trials. Revenue generated through project-based contracts for services including clinical monitoring, data management, biostatistics, project management, quality assurance, medical writing, and medical monitoring.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Peachtree BioResearch Solutions is a full-service Contract Research Organization (CRO) providing clinical development services for emerging to mid-sized biotechnology, pharmaceutical, and medical device sponsors. Its offering is built around eight interconnected service modules — Study Feasibility, Clinical Monitoring & Site Management, Project Management, Data Management, Biostatistics, Quality Assurance, Medical Writing, and Medical Monitoring — that together deliver end-to-end Phase I–III clinical trial execution with particular therapeutic depth in CNS, oncology, cardio-metabolic, renal, and rare diseases.

Product overview

Peachtree BioResearch Solutions operates as a full-service Contract Research Organization (CRO) offering an integrated platform of clinical research service modules. The company provides eight interconnected service offerings spanning the complete clinical trial lifecycle: Study Feasibility, Clinical Monitoring & Site Management, Project Management, Data Management, Biostatistics, Quality Assurance, Medical Writing, and Medical Monitoring. These modules work together to deliver end-to-end clinical research services to pharmaceutical, biotechnology, and medical device companies, with particular depth in CNS/neurology studies.

Differentiator

Problem solved

Functional benefit

Products and services

• Study Feasibility Clinical trial feasibility assessment combining scientific review, historical data benchmarking, and site identification to ensure study success; targeted at sponsors planning Phase I–IV clinical trials who need evidence-based site selection and design decisions.
• Clinical Monitoring & Site Management On-site and regionally-based clinical research associate (CRA) services ensuring subject safety, protocol compliance, and accurate data collection across investigative sites; targeted at sponsors needing consistent monitoring coverage across multi-center trials.
• Project Management Strategic leadership and day-to-day direction for clinical trials, providing timeliness, quality, and budget control through planning, communication, and proactive issue resolution; targeted at sponsors needing a single accountable lead across multi-functional trial teams.
• Data Management Clinical data management services including CRF design, database development, edit check programming, EDC integration, query management, and medical coding; targeted at sponsors who need clean, auditable clinical datasets across complex trial designs.
• Biostatistics Statistical consulting across all clinical study phases and designs, from protocol development through analysis and reporting; targeted at sponsors needing experienced industry biostatisticians to support study design and submission-ready analysis.
• Quality Assurance Clinical quality assurance services including site, sponsor, and vendor audits, inspection-readiness training, and fraud-detection training; targeted at sponsors who need to maintain GCP compliance and prepare for regulatory inspections over multi-year trials.
• Medical Writing Technical medical writing services for clinical documentation including investigator brochures, protocols, patient narratives, clinical study reports, and regulatory submissions; targeted at sponsors preparing regulatory and publication-grade documentation.
• Medical Monitoring Medical oversight of clinical trial projects ensuring protocol adherence and subject safety through medical monitoring plans and adverse event review; targeted at sponsors needing senior medical expertise embedded in study teams.

Quantifiable outcome

• 700+ Phase I-IV studies completed across drug, device, and biotech industries
• +5 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Julius ClinicalflagshipStrategic or Co-development Partner · 14 May 2025Julius Clinical, a leading full-service CRO headquartered in the Netherlands (Zeist), and Peachtree BioResearch Solutions announced a merger to form a fully integrated global CRO with enhanced CNS capabilities. The merger combines scientific and operational excellence, expanded international footprint across Europe and North America, and increased capabilities in CNS, cardio-metabolic, renal, and rare diseases. The combined organization brings together extensive expertise in managing Phase I-III clinical trials with particular depth in CNS disorders. Building on nearly a decade of successful collaboration between the two companies, the merged organization creates a comprehensive clinical CRO offering end-to-end clinical research services.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• ICON plc: Top-3 global CRO with comprehensive clinical development and laboratory services. Competes across the full range of study sizes and therapeutic areas including CNS.
• Syneos Health: Large full-service CRO and contract commercial organization offering end-to-end clinical and commercialization services. Competes with Peachtree on mid-sized biotech deals and CNS studies, but at much larger scale.
• IQVIA: World's largest CRO with full-service clinical development capabilities across all therapeutic areas. Dominant incumbent that Peachtree positions against by offering a more flexible, less bureaucratic alternative.

Direct peers

• Clinipace Worldwide: Mid-sized, therapeutically-focused CRO serving emerging to mid-sized biopharma with full-service capabilities. Comparable scale and customer-segment focus to Peachtree.
• Worldwide Clinical Trials: Mid-sized, therapeutically-focused CRO with industry-leading CNS and rare disease expertise. Most directly comparable to Peachtree in scale, therapeutic focus, and target sponsor segment.
• Premier Research: Specialty mid-sized CRO with deep CNS, oncology, and rare disease expertise serving small to mid-sized biotech sponsors. Highly comparable business model and customer segment.
• Signant Health (formerly MedAvante-ProPhase): Specialty clinical services provider focused on CNS clinical assessments, electronic clinical outcome assessments, and patient-centric solutions. Comparable in CNS focus and complementary technology-enabled services.
• Julius Clinical: European-based full-service CRO that merged with Peachtree in May 2025. Directly comparable in therapeutic focus (CNS, cardio-metabolic, rare disease) and mid-sized CRO positioning; the two are now part of the same combined entity.

Emerging players

• Veristat: Smaller clinical research organization specializing in complex therapeutic areas and statistical/regulatory services for emerging biotech. Comparable in focus on smaller sponsors and complex studies.

Others

• WCG (WIRB-Copernicus Group): Clinical services organization offering IRB, biosafety, and trial enablement services to CROs and sponsors. Operates in adjacent clinical trial services rather than direct CRO competition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/peachtree-bioresearch-solutions
• Xx.com/PeachtreeBRS

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Peachtree Bioresearch Solutions